{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:02:47Z","timestamp":1791525767561,"version":"4.3.4"},"reference-count":30,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dentistry Journal"],"abstract":"<jats:p>Trigeminal neuralgia is a chronic pain condition associated with sharp, shock-like pain in one or more divisions of the trigeminal nerve. For patients who do not respond well to pharmacotherapy, there is growing evidence that Botulinum toxin type A injections into the trigeminal ganglion provide pain relief for several weeks up to several months at a time. One option is to administer injections into the trigeminal ganglion in Meckel\u2019s cave by inserting a needle through the Pterygopalatine Fossa using fluoroscopy to guide and confirm the proper needle placement. However, there is evidence that Botulinum toxin travels across nerve synapses; thus, injecting directly into the trigeminal ganglion may not be necessary. We present two patients with a confirmed diagnosis of trigeminal neuralgia who were treated by injecting Botulinum toxin type A intraorally into the mental foramen which resulted in 6 months or longer of pain relief. Injections into the mental foramen are much easier to administer than those administered directly into the trigeminal ganglion, and both patients treated with this technique experienced comparable results to what can be expected from traditional fluoroscopy-guided botulinum toxin injections. Though more research is needed, these cases potentially imply that a less-invasive injection may be sufficient in managing trigeminal neuralgia-related pain.<\/jats:p>","DOI":"10.3390\/dj10110207","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T03:11:21Z","timestamp":1667445081000},"page":"207","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Management of Trigeminal Neuralgia with Botulinum Toxin Type A: Report of Two Cases"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4804-7062","authenticated-orcid":false,"given":"Craig","family":"Pearl","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9005-3840","authenticated-orcid":false,"given":"Brendan","family":"Moxley","sequence":"additional","affiliation":[{"name":"School of Dentistry, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Perry","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagi","family":"Demian","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyndie","family":"Dallaire-Giroux","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pain.2008.03.002","article-title":"Incidence rates and treatment of neuropathic pain conditions in the general population","volume":"137","author":"Dieleman","year":"2008","journal-title":"Pain"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410270114","article-title":"Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945\u20131984","volume":"27","author":"Katusic","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_3","unstructured":"Victor, M., and Ropper, A.H. (2001). Principles of Neurology, McGraw-Hill Companies Medical Publishing Division."},{"key":"ref_4","first-page":"e8522","article-title":"Sphenopalatine Ganglion Block: Treatment of Migraine and Trigeminal Neuralgia Associated with Multiple Sclerosis","volume":"12","author":"Nagib","year":"2020","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7224\/1537-2073.2016-065","article-title":"Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosis","volume":"19","author":"Fallata","year":"2017","journal-title":"Int. J. MS Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200201000-00004","article-title":"Pharmacotherapy of Trigeminal Neuralgia","volume":"18","author":"Sindrup","year":"2002","journal-title":"Clin. J. Pain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00701-007-1488-3","article-title":"Various surgical modalities for trigeminal neuralgia: Literature study of respective long-term outcomes","volume":"150","author":"Tatli","year":"2008","journal-title":"Acta Neurochir. (Wien.)"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1177\/0022034519875053","article-title":"Botulinum Toxin Type A in Dental Medicine","volume":"98","author":"Jabbari","year":"2019","journal-title":"J. Dent. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Waskitho, A., Yamamoto, Y., Raman, S., Kano, F., Yan, H., Raju, R., Afroz, S., Morita, T., Ikutame, D., and Okura, K. (2021). Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model. Toxins, 13.","DOI":"10.3390\/toxins13100704"},{"key":"ref_10","first-page":"e2","article-title":"The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: A Systematic Literature Review","volume":"11","author":"Rubis","year":"2020","journal-title":"J. Oral Maxillofac. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1129-2377-14-72","article-title":"Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: A systematic review","volume":"14","author":"Hu","year":"2013","journal-title":"J. Headache Pain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","article-title":"Botulinum toxin type A for the treatment of trigeminal neuralgia: Results from a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Wu","year":"2012","journal-title":"Cephalalgia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e8133","DOI":"10.1097\/MD.0000000000008133","article-title":"Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up","volume":"96","author":"Duman","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref_14","unstructured":"Alexander, C.E., and Dua, A. (2022, May 01). Sphenopalatine Ganglion Block, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557751\/."},{"key":"ref_15","first-page":"E537","article-title":"Ultrasound-guided trigeminal nerve block via the pterygopalatine fossa: An effective treatment for trigeminal neuralgia and atypical facial pain","volume":"16","author":"Nader","year":"2013","journal-title":"Pain Physician"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Moon, Y.E., Choi, J.H., Park, H.J., Park, J.H., and Kim, J.H. (2016). Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain. Toxins, 8.","DOI":"10.3390\/toxins8010018"},{"key":"ref_17","first-page":"73","article-title":"Botulinum toxin: Description of injection techniques and examination of controversies surrounding toxin diffusion","volume":"117","author":"Lim","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/j.bja.2021.02.020","article-title":"Sphenopalatine ganglion block: Do not give up on it just yet!","volume":"126","author":"Cometa","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/0333102416648328","article-title":"Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine","volume":"37","author":"Bratbak","year":"2017","journal-title":"Cephalalgia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ane.12906","article-title":"Botulinum toxin: A review of the mode of action in migraine","volume":"137","author":"Do","year":"2018","journal-title":"Acta Neurol Scand."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00002508-200503000-00010","article-title":"Injections of Botulinum Toxin Type A Produce Pain Alleviation in Intractable Trigeminal Neuralgia","volume":"21","author":"Allam","year":"2005","journal-title":"Clin. J. Pain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.14260\/jemds\/2021\/49","article-title":"Intraoral Botulinum Toxin Injection in Mental Foramen Site in the Treatment of Trigeminal Neuralgia","volume":"10","author":"Nvabazam","year":"2021","journal-title":"J. Evol. Med. Dent. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s10194-020-01149-8","article-title":"Pitfals in Recognition and Management of Trigeminal Neuralgia","volume":"21","author":"Antonaci","year":"2020","journal-title":"J. Headache Pain"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1042-3699(20)30594-X","article-title":"The Role of Nerve Blocks in the Diagnosis of Traumatic Trigeminal Neuralgia","volume":"4","author":"Campbell","year":"1992","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","article-title":"Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection","volume":"633","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1523\/JNEUROSCI.2618-11.2011","article-title":"Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT\/A)","volume":"31","author":"Restani","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","article-title":"Transsynaptic inhibition of spinal transmission by A2 botulinum toxin","volume":"591","author":"Akaike","year":"2013","journal-title":"J. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Marinelli, S., Vacca, V., Ricordy, R., Uggenti, C., Tata, A.M., Luvisetto, S., and Pavone, F. (2012). The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047977"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11916-009-0028-7","article-title":"The role of nerve blocks and botulinum toxin injections in the management of cluster headaches","volume":"13","author":"Ailani","year":"2009","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"25665","DOI":"10.1074\/jbc.M311515200","article-title":"Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity","volume":"279","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Dentistry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2304-6767\/10\/11\/207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:43Z","timestamp":1760144983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2304-6767\/10\/11\/207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["dj10110207"],"URL":"https:\/\/doi.org\/10.3390\/dj10110207","relation":{},"ISSN":["2304-6767"],"issn-type":[{"value":"2304-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]}}}